IN2014MU00495A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00495A
IN2014MU00495A IN495MU2014A IN2014MU00495A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A IN 495MU2014 A IN495MU2014 A IN 495MU2014A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A
Authority
IN
India
Prior art keywords
pharmaceutical compositions
abstract
cancer
preparing
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Geena Malhotra
Preeti Raut
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN495MU2014 priority Critical patent/IN2014MU00495A/en
Priority to PCT/GB2015/050384 priority patent/WO2015121649A1/en
Priority to ZA2015/00995A priority patent/ZA201500995B/en
Publication of IN2014MU00495A publication Critical patent/IN2014MU00495A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN495MU2014 2014-02-12 2015-02-12 IN2014MU00495A (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN495MU2014 IN2014MU00495A (zh) 2014-02-12 2015-02-12
PCT/GB2015/050384 WO2015121649A1 (en) 2014-02-12 2015-02-12 Pharmaceutical composition comprising vemurafenib
ZA2015/00995A ZA201500995B (en) 2014-02-12 2015-02-12 Low dose pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN495MU2014 IN2014MU00495A (zh) 2014-02-12 2015-02-12

Publications (1)

Publication Number Publication Date
IN2014MU00495A true IN2014MU00495A (zh) 2015-09-25

Family

ID=52544516

Family Applications (1)

Application Number Title Priority Date Filing Date
IN495MU2014 IN2014MU00495A (zh) 2014-02-12 2015-02-12

Country Status (3)

Country Link
IN (1) IN2014MU00495A (zh)
WO (1) WO2015121649A1 (zh)
ZA (1) ZA201500995B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3049926A1 (en) 2017-01-17 2018-07-26 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
US11504333B2 (en) * 2017-07-05 2022-11-22 Novartis Ag Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010232670B2 (en) * 2009-04-03 2015-07-09 F. Hoffmann-La Roche Ag Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
US20130172375A1 (en) * 2011-12-13 2013-07-04 Hoffmann-La Roche Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
WO2015121649A1 (en) 2015-08-20
ZA201500995B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
MX2023008686A (es) Polinucleotidos moduladores.
MX2020012165A (es) Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer.
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
MX2020003702A (es) Ciclopropilaminas como inhibidores de desmetilasa especifica de lisina 1 (lsd1).
MX2018008052A (es) Inhibidores de desmetilasa especifica de lisina 1 (lsd1).
PH12016501601A1 (en) Cyclopropylamines as lsd1 inhibitors
NZ735998A (en) Heterocyclic compounds as lsd1 inhibitors
MX2016015862A (es) Compuestos inhibidores de la cinasa de union a tank.
TW201613860A (en) Cyclopropylamines as LSD1 inhibitors
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
MX2016010216A (es) Composiciones farmaceuticas solidas de antagonistas de los receptores de androgenos.
IN2014MU00303A (zh)
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
PH12017500853A1 (en) Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases
IN2014CH00840A (zh)
IN2014MU00916A (zh)
IN2014MU00495A (zh)
GEP201706795B (en) Hexahydrofuropyrroles as pde1 inhibitors
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
EA201691620A1 (ru) Циклопропиламины в качестве ингибиторов lsd1